ATE491810T1 - Neuartiges nukleotidgemisch für eine verbesserte nukleinsäurenamplifikationsleistung - Google Patents

Neuartiges nukleotidgemisch für eine verbesserte nukleinsäurenamplifikationsleistung

Info

Publication number
ATE491810T1
ATE491810T1 AT08075840T AT08075840T ATE491810T1 AT E491810 T1 ATE491810 T1 AT E491810T1 AT 08075840 T AT08075840 T AT 08075840T AT 08075840 T AT08075840 T AT 08075840T AT E491810 T1 ATE491810 T1 AT E491810T1
Authority
AT
Austria
Prior art keywords
nucleic acid
acid amplification
novel nucleotide
nucleotide mixture
amplification performance
Prior art date
Application number
AT08075840T
Other languages
English (en)
Inventor
Brian Washburn
Douglas Lovern
Original Assignee
Bio Merieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux Inc filed Critical Bio Merieux Inc
Application granted granted Critical
Publication of ATE491810T1 publication Critical patent/ATE491810T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6846—Common amplification features
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AT08075840T 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für eine verbesserte nukleinsäurenamplifikationsleistung ATE491810T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53881404P 2004-01-23 2004-01-23
US53881504P 2004-01-23 2004-01-23
US53881604P 2004-01-23 2004-01-23

Publications (1)

Publication Number Publication Date
ATE491810T1 true ATE491810T1 (de) 2011-01-15

Family

ID=34812082

Family Applications (3)

Application Number Title Priority Date Filing Date
AT08075840T ATE491810T1 (de) 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für eine verbesserte nukleinsäurenamplifikationsleistung
AT05712046T ATE481507T1 (de) 2004-01-23 2005-01-21 Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'- nichttranslatierten bereichs von hcv
AT05722543T ATE417938T1 (de) 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT05712046T ATE481507T1 (de) 2004-01-23 2005-01-21 Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'- nichttranslatierten bereichs von hcv
AT05722543T ATE417938T1 (de) 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren

Country Status (6)

Country Link
US (3) US7364854B2 (de)
EP (3) EP2042612B1 (de)
JP (2) JP4866248B2 (de)
AT (3) ATE491810T1 (de)
DE (3) DE602005025424D1 (de)
WO (2) WO2005071117A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008134374A1 (en) * 2007-04-27 2008-11-06 Eragen Biosciences, Inc. Materials and methods for detection of hepatitis c virus
JP2009284896A (ja) * 2007-07-26 2009-12-10 Fujifilm Corp 核酸増幅方法
EP2058406A3 (de) * 2007-11-06 2009-10-28 Fujifilm Corporation RNA-Detektionsverfahren
JP2012513757A (ja) * 2008-12-31 2012-06-21 アボット・ラボラトリーズ Ｃ型肝炎ウイルスの検出用プライマー及びプローブ

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (ja) * 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk Ｃ型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法
EP0052296B1 (de) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Als Heilmittel für Immunokrankheiten anwendbare Glutaminderivate, Verfahren zu deren Herstellung und Zusammensetzungen, die die obengenannten Derivate enthalten
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
JPH0723393B2 (ja) * 1985-05-15 1995-03-15 アモコ・コーポレーション シチジン同族体
US4876187A (en) 1985-12-05 1989-10-24 Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
EP0419180B1 (de) 1989-09-18 1994-08-03 Canon Kabushiki Kaisha Tintenstrahlaufzeichnungskopf und Tintenstrahlgerät, welches diesen aufweist
EP0515506B1 (de) * 1990-02-16 2000-01-05 F. Hoffmann-La Roche Ag Verbesserungen in der spezifität und zweckmässigkeit der polymerase-kettenreaktion
WO1993022461A1 (en) 1992-05-06 1993-11-11 Gen-Probe Incorporated Nucleic acid sequence amplification method, composition and kit
US5648232A (en) * 1993-01-21 1997-07-15 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological best method and reagents
JP3062250B2 (ja) * 1994-03-10 2000-07-10 ジェン−プローブ・インコーポレイテッド イオン性界面活性剤による、酵素により媒介される反応に対する阻害の抑制方法
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
DE19612779A1 (de) * 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Verfahren zur spezifischen Vervielfältigung von langen Nukleinsäuren durch PCR
WO1998006736A1 (en) * 1996-08-14 1998-02-19 Life Technologies, Inc. Stable compositions for nucleic acid amplification and sequencing
DE19647055A1 (de) * 1996-11-14 1998-05-20 Boehringer Mannheim Gmbh Stabilisierte wässrige Nukleosidtriphosphat-Lösungen
EP2354251B1 (de) * 1997-04-03 2014-10-15 Life Technologies Corporation Verfahren und Produkte zur reversen Transkription gekoppelt mit Polymerasekettenreaktion (RT-PCR)
ZA989950B (en) * 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
EP1075508A2 (de) * 1998-04-27 2001-02-14 Ribozyme Pharmaceuticals, Inc. Enzymatische nukleinsäure zur hemmung der exprimierung und/oder replikation des hepatitis c-virus
WO2000000638A2 (en) 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
US6638714B1 (en) 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
DE60034884T2 (de) * 1999-06-04 2008-01-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
US6271004B1 (en) * 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
WO2001036442A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
AU2001254670A1 (en) 2000-03-02 2001-09-12 Akzo Nobel N.V. Detection of hepatitis b virus rna
CA2442092A1 (en) * 2001-03-26 2002-10-17 Ribozyme Pharmaceuticals, Inc. Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
WO2003016572A1 (en) * 2001-08-17 2003-02-27 Eli Lilly And Company Oligonucleotide therapeutics for treating hepatitis c virus infections
US6783940B2 (en) * 2001-10-31 2004-08-31 Applera Corporation Method of reducing non-specific amplification in PCR
US6750009B2 (en) 2002-01-29 2004-06-15 Apath, Llc Multiple viral replicon culture systems
AU2003241614A1 (en) 2002-05-24 2003-12-12 Smithkline Beecham Corporation Method for quantitating negative strand rna synthesis

Also Published As

Publication number Publication date
ATE417938T1 (de) 2009-01-15
WO2005070027A8 (en) 2006-07-27
JP2007518425A (ja) 2007-07-12
EP1706512A2 (de) 2006-10-04
WO2005070027A2 (en) 2005-08-04
WO2005071117A3 (en) 2006-04-20
US7670779B2 (en) 2010-03-02
EP1721015A2 (de) 2006-11-15
US20060019266A1 (en) 2006-01-26
WO2005070027A3 (en) 2006-04-06
US20060003343A1 (en) 2006-01-05
EP1706512B1 (de) 2008-12-17
DE602005023586D1 (de) 2010-10-28
EP2042612A2 (de) 2009-04-01
US20080248480A1 (en) 2008-10-09
JP4866248B2 (ja) 2012-02-01
EP1721015B1 (de) 2010-09-15
ATE481507T1 (de) 2010-10-15
WO2005071117A2 (en) 2005-08-04
US7364854B2 (en) 2008-04-29
DE602005025424D1 (de) 2011-01-27
EP2042612B1 (de) 2010-12-15
EP2042612A3 (de) 2009-06-17
DE602005011754D1 (de) 2009-01-29
JP2007518424A (ja) 2007-07-12

Similar Documents

Publication Publication Date Title
ATE557083T1 (de) Thermostabiler oder thermoactiver dna-polymerase mit abgeschwächter 3'-5' exonukleaseaktivität
ATE550441T1 (de) Verfahren, zusammensetzungen und kits zur isothermischen amplifikation von nukleinsäuren
BR0101493B1 (pt) mÉtodo para transcriÇço reversa e amplificaÇço de um rna usando dna polimerases mutantes.
NO20072507L (no) Reagenser og fremgangsmater for a bedre reproduserbarhet og redusere feil priming i PCR-amplifikasjon
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DE602007013223D1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
WO2008051530A3 (en) Polymerase enzymes and reagents for enhanced nucleic acid sequencing
DE60235491D1 (de) Paralleles scoring von polymorphismen mittels amplifikation und fehlerkorrektur
DE60230672D1 (de) Nukleinsäureanreicherung
DK1929012T3 (da) Fremgangsmåde til in vitro-rekombination
DK2357226T3 (da) Rationelt udformede meganukleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
IL225849A0 (en) Molecules with binding ability that can neutralize rabies virus, and their uses
PT2143803T (pt) Composições e métodos melhorados para a síntese de adnc
HK1074458A1 (en) Thermostable taq polymerase fragment
ATE484515T1 (de) Dna-polymerase-mischungen und mutante dna- polymerasen
SE0301951D0 (sv) New method
DE602005017252D1 (de) Verfahren zur amplifikation von nukleinsäuren mittels promotor-templates
ATE491810T1 (de) Neuartiges nukleotidgemisch für eine verbesserte nukleinsäurenamplifikationsleistung
ATE454476T1 (de) 3'-modifizierte oligonukleotide mit pseudoisocytosin-nukleobasenderivaten sowie deren anwendungen als primer oder sonden
DE60312507D1 (de) Eine methode zur in vitro molekularen evolution der proteinfunktion
WO2003004703A1 (en) Process for producing template dna and process for producing protein in cell-free protein synthesis system with the use of the same
ATE497022T1 (de) Verfahren zur amplifikation von nukleinsäure
DE60331072D1 (de) Verfahren zur unspezifischen amplifizierung nukleinsäuren mit niedriger komplexität
WO2010039189A3 (en) Methods for sequencing degraded or modified nucleic acids
ATE496122T1 (de) Thermostabile polymerase aus i thermococcus pacificus /i

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties